title: Scavenging effects of dopamine agonists on nitric oxide radicals.
abstract: It has recently been considered that free radicals are closely involved in the pathogenesis of Parkinson's disease (PD), and the level of nitric oxide radical (.NO), one of the free radicals, is reported to increase in PD brain. In the present study, we established a direct detection system for .NO in an in vitro .NO-generating system using 3-(2-hydroxy-1-methylethyl-2-nitrosohydrazino)-N-methyl-1-propa namine as an .NO donor and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO) by electron spin resonance (ESR) spectrometry and examined the quenching effects of the dopamine agonists pergolide and bromocriptine on the amount of.NO generated. .NO appeared to be scavenged by pergolide and, to a lesser extent, by bromocriptine. In the competition assay, the 50% inhibitory concentration values for pergolide and bromocriptine were estimated to be approximately 23 and 200 microM, respectively. It was previously reported that in vivo treatment of pergolide and bromocriptine completely protected against the decrease in levels of striatal dopamine and its metabolites in the 6-hydroxydopamine-injected mouse. Considering these findings, pergolide and probably bromocriptine may also protect against dysfunction of dopaminergic neurons because of its multiple effects; not only does it stimulate the presynaptic autoreceptors, but it also directly scavenges .NO radicals and hence protects against .NO-related cytotoxicity. This ESR spectrometry method using carboxy-PTIO may be useful for screening other drugs that can quench .NO.
authors.affiliation: Department of Neuroscience, Okayama University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Nishibayashi
authors.forename: M
authors.initials: M
authors.lastname: Asanuma
authors.forename: M
authors.initials: M
authors.lastname: Kohno
authors.forename: M
authors.initials: M
authors.lastname: Gómez-Vargas
authors.forename: N
authors.initials: N
authors.lastname: Ogawa
mesh_terms: D001565:Benzoates; D001971:Bromocriptine; D018491:Dopamine Agonists / Q000494:pharmacology*; D004578:Electron Spin Resonance Spectroscopy; D016166:Free Radical Scavengers; D005609:Free Radicals; D007093:Imidazoles; D007700:Kinetics; D009569:Nitric Oxide / Q000737:chemistry*; D010479:Pergolide; D013113:Spin Labels
chemical_list: D001565:Benzoates; D018491:Dopamine Agonists; D016166:Free Radical Scavengers; D005609:Free Radicals; D007093:Imidazoles; D013113:Spin Labels; C079393:1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole; D010479:Pergolide; D009569:Nitric Oxide; D001971:Bromocriptine